Harvard Apparatus Regenerative Technology (HRGN) has issued an update.
Mao Zhang, the CEO of Stellars Capital, has been appointed as a Class I director on the Board of a company, with his term lasting until the 2026 annual stockholders meeting. He will receive stock options and compensation aligned with other non-employee directors, including an immediate stock option grant worth $25,000 and annual compensation of $20,000 plus reimbursed expenses. Zhang has no familial ties to current directors or officers of the company. The company publicly announced his appointment the day after it was effective.
Learn more about HRGN stock on TipRanks’ Stock Analysis page.
